WALTHAM, Mass.--(BUSINESS WIRE)--Trinity Life Sciences, a leader in global life sciences solutions, announced the winners of the TGaS Best of Benchmark (BoB) Awards. The Awards, which are given for commercial operations excellence within the pharmaceutical industry, were presented to teams at Merck (known as MSD outside the United States and Canada), Gilead, Sanofi, Janssen Oncology, Genentech and Horizon Therapeutics. The BoBs are based on TGaS benchmarking of large, midsize and emerging life sciences companies.
While the specific BoB criteria subtly changes from function to function, the underlying factor for recognition is a commercial operations pharma team that demonstrates the best capability relative to peers in the industry for a specific department, function or process. Winners are chosen based on TGaS benchmarks and other benchmark-based project work that gives the Division a deep understanding of all eligible clients.
Due to COVID, the Awards were delayed; however, it allowed the selection committee to include companies whose projects were performed in the first half of 2020.
"The past few years have been very challenging for pharmaceutical companies. Pricing pressures, increasing managed care obstacles, and continued scrutiny on promotional practices that were defining pressures in 2019 were dwarfed suddenly in 2020 by COVID. Despite these challenges, commercial operations leaders have continued to support and drive the efficiency and effectiveness of pharmaceutical commercial operations,” said Gary McWalters, President, TGaS, a division of Trinity. "We introduced the Best of Benchmark Awards to honor excellence in the commercial operations area of pharma which is so essential to a company’s commercial success in the marketplace. Congratulations to this year’s Best of Benchmark winners."
Third Annual Best of Benchmark Award Winners:
- Commercial Analytics and Insights: Management - Merck
- Field Operations: Sales Analytics - Gilead
- Incentive Compensation: Incentive Compensation Excellence - Sanofi
- Learning & Development: Curriculum Design and Metrics - Janssen Oncology
- Marketing Operations: End-to-End Promotional Content Lifecycle Management and Marketing Operations - Genentech
- Omnichannel Marketing: KRYSTEXXA®- Paid Search Campaign - Horizon Therapeutics
- Omnichannel Marketing: Center of Excellence Digital Capabilities - Genentech
- Contracting & Analytics: Contract Analytics - Merck
About TGaS® Advisors
TGaS Advisors, a division of Trinity Life Sciences, is the leading benchmarking and advisory services firm for commercial organizations in the life sciences industry. With a roster of large, emerging and precommercial life sciences companies, TGaS provides robust comparative intelligence and collaborative network membership services. The team includes more than 50 experienced professionals, most with senior-level experience in the life sciences and related industries. To learn more about how TGaS is driving commercial excellence in the biopharmaceutical industry, visit www.tgas.com
About Trinity Life Sciences
Trinity Life Sciences is a trusted strategic partner, providing evidence-based solutions for the life sciences. With over 20 years of experience, Trinity is committed to solving clients’ most challenging problems through exceptional levels of service, powerful tools, and data-driven insights. Trinity’s range of products and solutions includes industry-leading benchmarking solutions, powered by TGaS Advisors. To learn more about how Trinity is elevating life sciences and driving evidence to action, visit trinitylifesciences.com.
